These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26851648)

  • 1. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.
    Zhou ZW; Ju HX; Sun MZ; Fu QP; Chen HM; Ji HB; Ji F; Jiang DM
    Clin Chim Acta; 2016 Apr; 455():113-7. PubMed ID: 26851648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
    Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H
    Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy.
    Zhao C; Hou J; Wang S; Jiang R
    Med Sci Monit; 2015 Jun; 21():1839-42. PubMed ID: 26110737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of various serum biomarkers with the severity of diabetic retinopathy.
    Nalini M; Raghavulu BV; Annapurna A; Avinash P; Chandi V; Swathi N; Wasim
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S451-S454. PubMed ID: 28420575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients.
    Yilmaz A; Yilmaz T; Gunay M
    Int Ophthalmol; 2018 Dec; 38(6):2445-2450. PubMed ID: 29071522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular responsiveness in type 2 diabetes mellitus (T2DM).
    Blum A; Socea D; Sirchan R
    QJM; 2016 Dec; 109(12):791-796. PubMed ID: 27289111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
    Lee IG; Chae SL; Kim JC
    Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.
    You QY; Zhuge FY; Zhu QQ; Si XW
    Int J Ophthalmol; 2014; 7(4):648-53. PubMed ID: 25161936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of MMP-2, TIMP-1, β2-MG and hs-CRP with the progression of retinopathy in patients with type 2 diabetes.
    Shi X; Yang M; Jiang X; Li Y; Meng L
    Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):147-151. PubMed ID: 37329533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Vascular Endothelial Growth Factor Levels Correlate with Severity of Retinopathy in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Zhou Z; Ju H; Sun M; Chen H
    Dis Markers; 2019; 2019():9401628. PubMed ID: 31019585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-423 may regulate diabetic vasculopathy.
    Blum A; Meerson A; Rohana H; Jabaly H; Nahul N; Celesh D; Romanenko O; Tamir S
    Clin Exp Med; 2019 Nov; 19(4):469-477. PubMed ID: 31422516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
    Kaviarasan K; Jithu M; Arif Mulla M; Sharma T; Sivasankar S; Das UN; Angayarkanni N
    Metabolism; 2015 Sep; 64(9):958-66. PubMed ID: 26004392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.
    Choudhuri S; Chowdhury IH; Das S; Dutta D; Saha A; Sarkar R; Mandal LK; Mukherjee S; Bhattacharya B
    Mol Cell Biochem; 2015 Jul; 405(1-2):265-79. PubMed ID: 25956512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy.
    Blum A; Socea D; Ben-Shushan RS; Keinan-Boker L; Naftali M; Segol G; Tamir S
    Eur Cytokine Netw; 2012; 23(4):158-62. PubMed ID: 23328414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM).
    Sajovic J; Cilenšek I; Mankoč S; Tajnšek Š; Kunej T; Petrovič D; Globočnik Petrovič M
    Bosn J Basic Med Sci; 2019 Feb; 19(1):94-100. PubMed ID: 30579324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fetuin-A concentrations are positively associated with serum VEGF levels in patients with newly diagnosed type 2 diabetes.
    Zhou Z; Ju H; Sun M; Chen H; Ji H; Jiang D; Ji Y; Ji J
    Endocr J; 2015; 62(10):879-85. PubMed ID: 26156593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
    Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
    Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.